Boehringer Ingelheim GmbH Profile last edited on: 9/25/2017
NO Business Identifier is currently available for this company. Year Founded
1885Last Involved Year
2018Key People / Management
John E Adamou -- Head, U.S. Strategic Tran
Bruce J Banks --
James Chafouleas --
Laurie Churchill --
Tony Fraij --
Roger J Hill --
Roger J Hill --
Jason Kelley --
Edouard G Lebel --
Leonetti Leonetti --
Steven D Marlin --
Steven D Marlin -- Vice President
Christoph Pittius --
Alexia Priest --
Timothy X Witkowski --
Kevin Xie --
Bruce J Banks --
James Chafouleas --
Laurie Churchill --
Tony Fraij --
Roger J Hill --
Roger J Hill --
Jason Kelley --
Edouard G Lebel --
Leonetti Leonetti --
Steven D Marlin --
Steven D Marlin -- Vice President
Christoph Pittius --
Alexia Priest --
Timothy X Witkowski --
Kevin Xie --
Location Information
Binger Strasse 173
Ingelheim, GR 55216
Ingelheim, GR 55216
| (496) 132-770 |
| www.boehringer-ingelheim.com |
Public Profile
Boehringer Ingelheim Pharma GmbH & Co. KG develops, manufactures, and supplies active pharmaceutical ingredients and intermediates for the health care industry. It offers active pharmaceutical ingredients, generics, intermediates, phytochemicals, and organic mineral salts. Boehringer Ingelheim also provides services, such as process development of complicated multistep synthesis, analytical support, adaptation and scaling up of processes, batches and production of commercial quantities, and regulatory support. The company is based in Ingelheim am Rhein, Germany. Boehringer Ingelheim Pharma GmbH & Co. KG operates as a subsidiary of C.H. Boehringer Sohn AG & Co. KG Human Pharmaceuticals and Animal Health
Extent of SBIR involvement
Synopsis: Techseeker Business Condition
Headquartered
GermanyEmployment
41,300Revenue
$14.7BPublic/Private
Privately HeldStock Info
----Received SBIR $$
NoTechseeker firm in the news
There are no news available.
